Explore FOXO4-DRI, a synthetic senolytic peptide, its mechanism, preclinical anti‑aging data, and how Your Peptide Brand enables compliant RUO distribution for clinics seeking research‑grade products.
A data‑driven guide on MOTS‑c, the mitochondria‑derived peptide that modulates metabolism, has been studied for effects on insulin sensitivity, and shows promise for longevity research—all framed under RU O compliance.
Explore PT‑141 (bremelanotide)’s melanocortin mechanism, clinical background, and how Your Peptide Brand enables compliant RUO research and white‑label solutions for clinics.
A data‑driven guide for clinics on leveraging Alprostadil (PGE1) as a Research Use Only peptide, covering mechanism, research efficacy, regulatory compliance, and white‑label business opportunities.
A data‑driven guide on Epithalon’s telomerase activation research, compliance for RUO peptides, and how clinics can launch a white‑label offering.
End of content
End of content
